Trial intelligence / Profile preview

EXACTT: Tiotropium Exercise Endurance in COPD

NCT00525512Phase 4Completed

Sponsor
Boehringer Ingelheim
Start
Aug 2007
Primary completion
Jun 2010
Modality
Small Molecules
Countries
11
01

Overview

A Phase 4 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Aug 2007; status: completed.

02

Drugs

tiotropium
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00525512.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00525512.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call